NINDS NeuroNEXT Network — OTA Clinical Trials
Supports exploratory neurological clinical research through collaborative exploratory transactions.
The NINDS NeuroNEXT Network funds exploratory clinical trials and biomarker studies for neurological diseases through a two-stage Other Transaction Authority (OTA) process. Stage 1, governed by OTA-24-013, is the preliminary application in which investigators describe the proposed trial or study concept; only applications that pass Stage 1 review may proceed to Stage 2 under OTA-24-014, which requ…
Exploratory clinical trials and biomarker studies for neurological diseases conducted within the NeuroNEXT clinical trials network.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NINDS
All grants from this funder →NINDS SBIR Phase I
🇺🇸NINDS · United States
Funds small-business feasibility research for neuroscience technologies advancing toward later commercialization in the United States.
NINDS STTR Phase I
🇺🇸NINDS · United States
Supports small businesses and neuroscience teams pairing with research institutions.
NINDS R01/R21/R03 Research Project Grants — Investigator-Initiated
🇺🇸NINDS · United States
Funds neuroscience research in the United States through investigator-driven grants across basic, translational, and clinical areas.
NIH Blueprint MedTech Translator
🇺🇸NINDS · United States
Funds translational neurotechnology device development through structured milestones and multi-year collaboration.
Similar grants
Browse the directory →
INCLUDE Project — Clinical Trials Phased Awards
🇺🇸NICHD · United States
Funds phased clinical research programs for Down syndrome interventions through developmental and expansion awards.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
BARDA Accelerator Network — Proof-of-Concept Funding
🇺🇸BARDA · United States
Supports United States health-security teams with early milestone-based funding for proof-of-concept countermeasure work.
NIH HEAL Initiative — Open NOFOs
🇺🇸NIH · United States
Supports opioid, pain, and substance use disorder research in the NIH HEAL portfolio.
NIH IGNITE Program — R61/R33 Phased Neurotherapeutic Grants
🇺🇸NIH · United States
Supports early neurotherapeutic translation through milestone-based translational funding.
NICHD R21 Exploratory/Developmental Grant
🇺🇸NICHD · United States
Supports high-risk exploratory projects in NICHD research areas through small pilot grants in the United States.